Hayat Pharmaceutical Industries Co. PLC announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was JOD 3.579 million compared to JOD 2.343 million a year ago. Net income was JOD 538,197 compared to JOD 162,320 a year ago. Basic earnings per share from continuing operations was JOD 0.06 compared to JOD 0.02 a year ago. For the half year, sales was JOD 9.283 million compared to JOD 7.656 million a year ago. Net income was JOD 2.566 million compared to JOD 1.639 million a year ago. Basic earnings per share from continuing operations was JOD 0.3 compared to JOD 0.2 a year ago.